Left unilateral behavioral disorder with diagonistic dyspraxia following callosal and right centrum semiovale lesions: Implications for interhemispheric and fronto-parietal motor connectivity.

CortexJun 5, 2026 (epub)
Case ReportNeurology

Nami Ihori, Nonoka Kuboshima, Shigeo Araki et al.

✦ AI-curated · Sources linked

Case in brief

A 58-year-old right-handed patient exhibited diagnostic dyspraxia of the left hand due to infarct lesions in the right centrum semiovale and corpus callosum. Symptoms included involuntary actions of the left hand, such as mirroring the right hand's movements and grasping objects without intention. Linguistic tests revealed errors in the left hand during both verbal commands and imitation tasks, indicating complex interhemispheric and intrahemispheric disconnection.

What made this case unusual

The patient displayed involuntary grasping and release behaviors not typically associated with classic diagnostic dyspraxia, highlighting a unique presentation linked to specific brain lesions.

Diagnostic / clinical pearl

Clinicians should consider the possibility of dual disconnection mechanisms in patients with dyspraxia, particularly when symptoms include involuntary movements and atypical grasping behaviors.

Why it matters

Understanding the interplay between interhemispheric and intrahemispheric connectivity can enhance the diagnosis and management of motor disorders following specific brain lesions.

Source

Published in Cortex. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.